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Purpose: As recently reported, the short-term results of the tension-free vaginal tape 
SECUR
Ⓡ (TVT-S) procedure seem to be similar to those of the conventional trans-
obturator tape (TOT) procedure. However, results of efficacy and satisfaction with 
TVT-S are insufficient in patients with more than 1 year of follow-up. Therefore, we 
evaluated the results of the TVT-S procedure in women with stress urinary incon-
tinence (SUI) during 2 years.
Materials and Methods: We evaluated 51 patients with clinical and urodynamic diag-
noses of SUI who underwent the TVT-S procedure from March 2008 to February 2009. 
Preoperative evaluation included a history, cough stress test with full bladder, urody-
namic study, and incontinence quality of life (I-QoL) questionnaire. Following the post-
operative period, urinary incontinence status was examined through a physical exami-
nation and the I-QoL questionnaire was completed in an outpatient setting or by 
telephone.
Results: Data from 2 years of follow-up were available for 46 of 51 patients. The cure 
rate was 80.4% at 1 month after TVT-S and 76.0% at 2 years after TVT-S. The cure or 
improvement rate was 93.5% at 1 month after TVT-S and 86.8% at 2 years after TVT-S. 
The mean total I-QoL score increased by 42 points at 1 month after TVT-S (p＜0.026) 
and by 32 points at 2 years after TVT-S (p＜0.013). Most patients reported significant 
improvements in quality of life. At the 2-year follow-up, there were no significant com-
plications related to TVT-S.
Conclusions: The results of this study suggest that TVT-S is an efficient and safe proce-
dure for the improvement of both the quality of life of the patients and the SUI itself.
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INTRODUCTION
Stress urinary incontinence (SUI) adversely affects the 
quality of life and well-being of approximately 15% of the 
female population [1]. The treatment options for SUI in-
clude retropubic suspensions and slings, transobturator 
tape procedures, injectable bulking agents, and less com-
monly, artificial urinary sphincter placement [2]. The ret-
ropubic tape has been shown to be effective for many years, 
but exposes the patient to serious complications, such as 
bladder perforation, principally because of the use of the 
retropubic space for the fixation of the tape [3]. In an at-
tempt to avoid the retropubic space, the second generation 
of slings, the transobturator tape, was introduced. The re-
cent generation of midurethral slings, the tension-free vag-
inal tape SECUR
Ⓡ (TVT-S, Gynecare, Ethicon, Somerville, Korean J Urol 2011;52:335-339
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TABLE 1. Clinical characteristics of the patients treated with the
TVT-S
Variables Values
Mean age (yr) 57.89 (41-77)
Mean parity (range) 3.07 (1-6)
Mean BMI (kg/m
2) 25.54 (21-35)
Mean symptom duration (yr) 5.09 (1-15)
Mean follow-up (mo) 25.16 (24-34)
No. with presence of urge urinary
  incontinence (%)
     5 (10.8)
No. Stamey symptom grade I (%)    27 (58.6)
II (%)    19 (41.4)
No. with presence of POP (%)    17 (36.9)
No. with history of previous anti-
incontinence surgery (%)
   2 (4.3)
Mean maximum flow rate (ml/s) 26.32 (10-48)
Mean postvoid residual volume (ml) 17.53 (10-70)
Mean VLPP (cmH2O) 85.16 (50-95)
Mean MUCP (cmH2O) 52.53 (13-74)
TVT-S: tension-free vaginal tape-Secur, BMI: body mass index, 
POP: pelvic organ prolapse, VLPP: Valsalva leak point pressure,
MUCP: maximum urethral closure pressure
TABLE 2. Comparison of preoperative and postoperative I-QoL scores
Subscales Baseline 1 month 2 years p-value
a p-value
b
I-QoL Total 35.44 77.31 67.57 ＜0.026 ＜0.013
Avoidance and limiting behaviors 36.80 76.94 73.52 ＜0.034 ＜0.021
Psychosocial impacts 39.61 79.89 65.35 ＜0.045 ＜0.046
Social embarrassment 25.78 73.28 71.23 ＜0.001 ＜0.023
I-QoL: incontinence quality of life, 
a: comparison of baseline vs 1 month, 
b: comparison of baseline vs. 2 years
NJ, USA), which was introduced in 2005, attempts to lower 
the number of complications by involving only a small vagi-
nal incision and no exit wound. 
　As recently reported, the short-term results of the TVT-S 
procedure seem to be similar to those of the conventional 
‘outside-in’ technique of the transobturator route for sub-
urethral tape placement, i.e., the transobturator tape (TOT) 
procedure. However, results of efficacy and satisfaction 
with TVT-S are lacking in patients with long-term follow- 
up [4]. Therefore, we evaluated the long-term results of the 
TVT-S procedure in women with SUI.
MATERIALS AND METHODS
This study was conducted in the urology division at our na-
tional university hospital between March 2008 and Feb-
ruary 2009. During this period, the TVT-S procedure was 
performed for all patients with clinical and urodynamic di-
agnoses of SUI who needed anti-incontinence surgery. 
Patients who had urinary tract infection, urogynecological 
malignancy, or neurogenic bladder were excluded from the 
study. The population consisted of 51 women who under-
went the TVT-S procedure. The surgery was done under 
general or spinal anesthesia by one experienced surgeon. 
The surgical approach of the TVT-S procedure was through 
the U approach. The patients included in the study had SUI 
or stress-predominant mixed urinary incontinence proven 
by urodynamic study. Preoperative evaluation included a 
history, cough stress test with full bladder, urodynamic 
study, and incontinence quality of life (I-QoL) question-
naire. All subjects underwent a pelvic examination in the 
seated semilithotomy position with a Valsalva maneuver. 
The pelvic organ prolapse quantification (POP-Q) stand-
ard scoring system was adopted for staging. Because the 
degree of POP was minimal, surgical management for pel-
vic organ prolapse was not performed. Following the post-
operative period, urinary incontinence status was exam-
ined through a physical examination, and the I-QoL ques-
tionnaire was completed in an outpatient setting or by 
telephone.
　Cure was defined as the absence of any episodes of in-
voluntary urine leakage during stressful activities and a 
stress test. Improvement was defined as a significant re-
duction in urine leakage, such that it did not require further 
treatment. 
　Statistical analysis of the data was performed by using 
Student’s t-test. SPSS ver. 17.0 (SPSS Inc., Chicago, IL, 
USA) was used for the data analysis. Statistical signifi-
cance was set at p＜0.05.
RESULTS
The population included 46 patients. Five patients were ex-
cluded because of loss to follow-up. The mean age of the pop-
ulation was 57.89 years (range, 38-85 years), mean parity 
was 3.07 (range, 1-6), mean body mass index was 25.54 
kg/m
2 (range, 21-35 kg/m
2), and mean symptom duration 
was 5.09 years (range, 1-15 years). The mean follow-up pe-
riod was 25.16 months (range, 24-34 months). Urge urinary 
incontinence was present in 5 patients (10.8%). Stamey 
symptom grade 1 was present in 27 patients (58.6%) and 
grade 2 was present in 19 patients (41.4%). POP was pres-
ent in 17 patients (36.9%), and 2 patients (4.3%) had under-
gone a previous anti-incontinence surgery. The mean max-
imum flow rate was 26.32 ml/s (range, 10-48 ml/s), and 
mean postvoid residual volume was 17.53 ml/s (range, 
10-70 ml/s). Mean Valsalva leak point pressure was 85.16 
cmH2O (range, 50-95 cmH2O), and mean maximum ure-
thral closure pressure was 52.53 cmH2O (range, 13-74 
cmH2O) (Table 1).Korean J Urol 2011;52:335-339
2-Year Outcomes of TVT-Secur 337
TABLE 3. Surgical outcomes of TVT-S
1 month 2 years
Success
　Cure (%) 80.4 (37/46) 76.0 (35/46)
　Improvement (%) 13.1 (6/46) 10.8 (5/46)
Failure (%) 6.5 (3/46) 13.2 (6/46)
TVT-S: tension-free vaginal tape-Secur
TABLE 4. Results of urodynamic study in the cure or improvement
group compared with the failure group
Cure or 
improvement 
group (n=40)
Failure 
group 
(n=6)
Mean maximum flow rate (ml/s) 26.43 25.58
Mean postvoid residual volume (ml) 15.32 32.26
Mean VLPP (cmH2O) 87.27 71.09
Mean MUCP (cmH2O) 52.64 51.79
VLPP: Valsalva leak point pressure, MUCP: maximum urethral
closure pressure
　The preoperative mean total I-QoL score was 35.44. One 
month after the operation, the mean total I-QoL score was 
77.31 (Table 2). Two years after the operation, the mean 
total I-QoL score was 67.57. Mean total I-QoL scores in-
creased 42 points at 1 month and 32 points at 2 years after 
TVT-S (p＜0.026, p＜0.013) (Table 2). Most patients re-
ported significant improvements in quality of life.
　The overall cure rate was 80.4% at 1 month after TVT-S 
and 76.0% at 2 years after TVT-S. The overall cure or im-
provement rate was 93.5% at 1 month and 86.8% at 2 years 
after TVT-S. The failure rate was 6.5% at 1 month and 
13.2% at 2 years after TVT-S (Table 3). 
　Results of urodynamic study in the cure or improvement 
group compared with the failure group were obtained. In 
the cure or improvement group, mean maximum flow rate, 
mean Valsalva leak point pressure, and mean maximum 
urethral closure pressure were higher than in the failure 
group. Mean postvoid residual volume was lower in the 
cure or improvement group (Table 4). The statistical sig-
nificance of these differences could not be determined, how-
ever, because of the limited number in the failure group.
　Three patients (6.5%) had urinary retention after sur-
gery, which was managed with temporary clean inter-
mittent catheterization. De novo urgency developed in 4 
patients (8.6%). Among 5 patients who had urge urinary 
incontinence before the operation, 2 patients had persis-
tent urge urinary incontinence. No vaginal or urethral ero-
sion was identified. At the 2-y follow-up, there were no sig-
nificant complications related to TVT-S.
DISCUSSION
Before 1996, SUI was optimally treated with one of several 
forms of retropubic colposuspension, the pubovaginal sling, 
injectable bulking agents, or needle suspension [2]. Although 
associated with acceptable “cured/dry” rates, each of these 
procedures is subject to inherent complications, is cumber-
some to perform or difficult to learn, or is associated with 
unacceptable morbidity [5-7]. The TVT, whose design was 
determined from the integral theory’s focus on midurethral 
continence, offered a less-invasive, outpatient-based treat-
ment option for SUI [3]. However, the TVT procedure has 
been associated with specific risks, including bladder, bow-
el, and vascular injury, owing to the blind passage of the 
trocars through the retropubic space [8]. In response to 
these risks, the TVT procedure was modified, and the TOT 
procedure was introduced in 2001 [9]. Instead of trans-
gressing the retropubic space, the TOT procedure passes 
the trocars blindly through the obturator foramen in an 
“inside-out” or “outside-in” fashion that thus obviates the 
risk of injury to the retropubic organs. Although promising, 
the TOT procedure has been associated with a small, but 
defined, risk of prolonged leg pain, ostensibly owing to pas-
sage of the transvaginal mesh through the obturator fora-
men proper [10]. The conventional TOT approach has re-
solved some of these problems by passing the obturator fos-
sa to avoid getting in the retropubic space, so that the tape 
is far enough away from the bladder, vessels, and bowel 
[11]. However, even this revolutionary approach is asso-
ciated with some complications, such as thigh pain, hema-
toma due to significant intraoperative bleeding, and post-
operative bladder outlet obstruction [12]. 
　TVT-S was planned to reduce the invasiveness of the 
tape procedure by developing a new tape. The principal 
idea of this novel technique was to introduce a midurethral 
sling from a single incision without passing the retropubic 
space or the obturator foramen and its related nerves and 
vessels [13]. The TVT-S procedure utilizes a shorter sling 
(8 cm) that is anchored directly to the retropubic fascia (U 
method) or the obturator internus muscle (H method). 
These steps lead to less dissection, lower amounts of syn-
thetic material, and possibly fewer complications. Exit 
points are unnecessary, which reduces the immediate and 
persistent pain.
　Gagnon and Tu reported that improvement in incon-
tinence symptoms was much higher with the U Method 
than with the Hammock technique [14]. The success rate 
increased with time, reaching a statistically significant dif-
ference at 6 months with 100% (22/22) improvement com-
pared with 69% (11/16) for the Hammock technique. The 
U Method seems to offer better support to the urethra and 
a stronger fixation of the mesh. The tightness applied to the 
tape during the surgery is also important for obtaining good 
results [14]. Accordingly, the surgical approach of the 
TVT-S procedure was through the U approach in our study.
　A small number of published articles are available on the 
TVT-S. Reported success rates for the TVT-S are about 80% 
[14]. To our knowledge, the first report came from Martan 
et al in January 2007 [15]. At 1 to 3 months of follow-up, 
they reported a cure rate of 93% in 15 patients, 10 with the 
Hammock technique. In 2008, Debodinance et al published Korean J Urol 2011;52:335-339
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an article on 110 patients with a dry rate of 70.4% at 2 
months [16]. This report actually revealed a low cure rate 
compared with conventional midurethral slings, but the 
technique was the Hammock technique in 85.5%. More re-
cently, Oliveira et al reported, in January of 2009, good suc-
cess rates in 107 patients with a mean follow-up of 15 
months. The patients were either dry or improved in 85% 
[17]. In our study, the overall cure or improvement rate was 
93.5% at 1 month after TVT-S and 86.8% at 2 years after 
TVT-S. Oliveira et al reported that the cure rate was 83% 
after TVT-O, 67% after TVT-S, and 87% after Mini-Arc [18]. 
The fact that TVT-S has been associated with lower success 
rates deserves some consideration. TVT-S has a long learn-
ing curve. Even among experienced surgeons, consistent 
positioning of the TVT-S tip maybe difficult. Moreover, 
mesh detachment from the introducer blades requires a 
twisting movement that may enlarge the internal ob-
turator muscle area where the TVT-S tip is inserted, thus 
compromising mesh adhesion [18]. But, according to Jeong 
et al, there was no significant difference in cure rate or pa-
tient satisfaction between the TVT-S and MONARC proce-
dures after more than 1 year of follow-up [4]. In our study, 
the TVT-S procedure was shown to offer relatively good re-
sults and a significant improvement in quality of life among 
women with SUI. 
　Because the questionnaire is a subjective measure, it 
should be convenient and easily understood. The I-QoL is 
easily self-administered and takes approximately 5 mi-
nutes for the average patient reading at a fifth-grade level 
to complete [19]. It is available in 16 different language ver-
sions and has been validated in four European countries 
as well as in the United States [20]. Also, we used the Korean 
version of the I-QoL. The I-QoL questionnaire is a targeted 
condition-specific questionnaire that assesses the effect 
and distress of specific symptoms of SUI [21,22]. The I-QoL 
contains 22 items, each with a five-point, Likert-type re-
sponse scale, yielding a total score and three subscale 
scores. The potential advantage of the I-QoL over previous 
measures is its applicability to patients over a range of ages 
and with varying types and severities of SUI.
　In our study, based on the outcome of the I-QoL, the pa-
tients experienced a significant improvement in their qual-
ity of life with the TVT-S procedure. 
CONCLUSIONS
The TVT-S procedure has a cure rate similar to that of the 
current TVT or TOT procedures, and the TVT-S procedure 
can be performed safely. From our experience, the TVT-S 
procedure offers a good success rate and a significant im-
provement in quality of life among women with SUI. We 
suggest that the TVT-S procedure is an efficient surgical 
treatment for improving the aspect of the quality of life of 
patients as well as SUI itself. However, controversy re-
mains about the difference in success rates of the TVT-S 
procedures between medical centers. Also, the TVT-S pro-
cedure has a long learning curve.
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